National MAQSTEM Research, Innovation & Advancement

NATIONAL MAQSTEM RESEARCH, INNOVATION & ADVANCEMENT

POSITION

The United States should invest public money in MAQSTEM: Medicine, Artificial Intelligence, Quantum science and computing, Science, Technology, Engineering, and Mathematics. Public investment is justified when the likely benefit is national in scale and private investment alone is unlikely to produce the needed work soon enough. It should expand knowledge, protect life, strengthen national security, build American capability, and produce measurable public value. It should not become political favoritism, permanent corporate support, or a blank check.

OUR PHILOSOPHY

Some discoveries require years of uncertain work before a profitable product exists. The public sector can responsibly support that early work while private companies compete to turn successful discoveries into useful products. Government should fund the public need, not choose permanent winners. Researchers should have room to investigate difficult questions, taxpayers should be able to see what their money accomplished, and the public should receive a fair return when public money materially creates a valuable commercial product.

WHAT MAQSTEM INCLUDES

  • Medicine: medical and biomedical research, prevention, diagnostics, pharmaceuticals, treatments, medical devices, clinical science, rehabilitation, and public health.

  • Artificial Intelligence: machine learning, responsible automation, data science, advanced models, robotics, safety, security, and practical applications serving the public.

  • Quantum: quantum physics, materials, sensing, communications, encryption, simulation, and computing.

  • Science: biology, chemistry, physics, astronomy, earth science, environmental science, materials science, and the other physical and life sciences.

  • Technology: computers, hardware, software, cybersecurity, communications, electronics, biotechnology, robotics, advanced manufacturing, and emerging technologies.

  • Engineering: aerospace, biomedical, chemical, civil, computer, electrical, environmental, industrial, materials, mechanical, nuclear, and other engineering disciplines.

  • Mathematics: pure and applied mathematics, statistics, modeling, operations research, algorithms, and quantitative analysis.

PUBLIC-INVESTMENT TEST

A major federal research or innovation award should satisfy a written public-investment test before money is committed. The responsible agency must identify:

  • the national problem, scientific question, or public capability the project addresses;

  • why private capital, ordinary procurement, or existing research is unlikely to meet the need adequately;

  • the expected public benefit and the people or systems expected to benefit;

  • the technical, ethical, financial, security, and commercialization risks;

  • specific milestones, decision points, responsible officials, and conditions for stopping or restructuring the project;

  • how duplication with other federal, state, university, nonprofit, or private programs was checked;

  • the intended public return, access conditions, intellectual-property treatment, and domestic-capability requirements.

PRIORITY AREAS

Priority may be given to work involving basic science, prevention and treatment of serious disease, medical diagnostics, public-health readiness, advanced manufacturing, semiconductors, energy production and storage, agriculture and food security, water, transportation, space, cybersecurity, quantum science, advanced computing, critical materials, environmental restoration, and technologies necessary for national defense or resilient infrastructure. This list establishes eligible national interests. It does not guarantee funding to a particular institution, company, technology, or theory.

USE THE RIGHT FUNDING TOOL

  • Basic research: Use competitively reviewed grants and cooperative agreements when the primary product is knowledge, data, methods, or early discovery.

  • Defined technical goals: Use milestone contracts, challenge prizes, and staged demonstrations when government can state the result it needs without dictating the only possible method.

  • Commercial development: Use cost sharing, repayable financing, royalties, warrants, equity, purchase commitments, or other enforceable public-return terms when the project is close to market and a private recipient may receive substantial commercial value.

  • Public infrastructure and laboratories: Preserve federal laboratories, shared facilities, datasets, test ranges, and research infrastructure when common access creates more value than a single private owner could provide.

OPEN COMPETITION, PEER REVIEW & QUICK DECISIONS

  • Major opportunities must use public eligibility rules, scored criteria, conflict disclosures, and reviewers with relevant scientific, technical, financial, ethical, and end-user expertise.

  • Agencies must acknowledge an application and identify missing material within 15 calendar days.

  • An initial award decision should ordinarily be issued within 90 calendar days after a complete application. A complex-program extension must identify the unresolved issue and a firm decision date.

  • Urgent national challenge programs may use a 30-day decision process if competition, technical review, conflicts screening, and written reasons are preserved.

  • Unsuccessful applicants must receive their scores and a meaningful explanation. Material process errors may be appealed to an independent review official within 15 business days.

SCIENTIFIC INDEPENDENCE & RESEARCH INTEGRITY

Awards may not use party loyalty, lawful political belief, personal relationships, race, religion, sex, or ideological conformity as a substitute for scientific merit and lawful program needs. Review panels must disclose conflicts. Research misconduct, fabricated results, hidden financial interests, and deliberate suppression of material safety findings must be investigated promptly. Honest disagreement, negative results, failed hypotheses, and good-faith scientific error are not fraud.

A FAIR RETURN FOR TAXPAYERS

Every award must state in advance what the public receives. Basic-research awards should ordinarily require timely publication and public access to results and data after a reasonable period for patent filing, privacy protection, and national-security review. Commercial-development awards should include one or more enforceable return mechanisms proportionate to the public contribution, such as repayment, royalties, equity, price or access commitments, domestic production, supply guarantees, open licensing after nonuse, or a government-use license.

A recipient may earn a reasonable profit for taking risk, adding private capital, completing development, manufacturing, and bringing a useful product to market. It may not accept public financing, conceal the public contribution, move the resulting capability abroad without review, and charge the public as though taxpayers contributed nothing.

MILESTONES, AUDITS & FAILURE

  • Funding should be released by defined stage rather than committed automatically for the full project.

  • Recipients must maintain records linking public money to personnel, equipment, subawards, milestones, deliverables, intellectual property, and conflicts of interest.

  • A missed milestone triggers technical review, not automatic punishment. Government may revise, pause, compete, transfer, or end a project when the evidence no longer supports continued investment.

  • Unused funds and money obtained through material misrepresentation must be recovered. Knowing fraud, kickbacks, fabricated data, or concealed conflicts trigger restitution, civil penalties, debarment, termination, and criminal referral where the legal elements are proven.

WHAT WE WILL MEASURE

Public reporting should track application and decision time, competition, independent review, milestones reached, failed projects, publications, validated discoveries, patents and licenses, products reaching use, lives or costs affected where measurable, private investment attracted, domestic production created, taxpayer returns, access commitments, safety findings, recoveries, and unresolved conflicts. Patent count or money spent alone does not prove success.

Core MPA standard: America should lead in MAQSTEM and invest in discoveries and capabilities that serve the public, especially where the benefit is large and the path is too uncertain or too long for private capital alone. Fund the mission. Test the work. Stop failed spending. Share the public benefit.

Related policies: Healthcare; Public Health & Emergency Powers; Education; Energy; National Cybersecurity Standards & Trusted Personnel; Infrastructure Modernization & Disaster Response; Public Money, Audits & Proof of Spending.

Status: Proposed / Draft, not yet formally adopted.

Originally published: September 27, 2026.

Last updated: September 27, 2026.

Version: Draft 0.1.

Previous
Previous

Workplace Freedom & Viewpoint-Neutral Employment

Next
Next

Nonprofit, NGO & Public Funding Accountability